Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation-Reference-Cited by-同舟云学术

Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation

Published:2019-04 Issue:15 Volume:294 Page:5980-5992
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Fernandes Vanessa C.^ORCID,Golubeva Volha A.,Di Pietro Giuliano^ORCID,Shields Cara,Amankwah Kwabena,Nepomuceno Thales C.,de Gregoriis Giuliana^ORCID,Abreu Renata B.V.^ORCID,Harro Carly,Gomes Thiago T.,Silva Ricceli F.,Suarez-Kurtz Guilherme,Couch Fergus J.^ORCID,Iversen Edwin S.,Monteiro Alvaro N.A.^ORCID,Carvalho Marcelo A.^ORCID

Funder

DHSC | National Institutes of Health

Division of Cancer Prevention, National Cancer Institute

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação do Câncer

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference42 articles.

1. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE;Mavaddat;J. Natl. Cancer Inst,2013